TOVX vs ZTS · rev $300.0K vs P/E 25, rev $2.47B
Theriva Biologics Inc. (TOVX) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
TOVX currently screens at market cap $12.4M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the TOVX and ZTS stock pages for the full models.
Not investment advice.